Company logo

MASI - Masimo Corporation

NASDAQ -> Healthcare -> Medical Instruments & Supplies
Irvine, United States
Type: Equity

MASI price evolution
MASI
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $163 $124.4 $150.7 $174.1
Short term investments
Net receivables $355.5 $356.9 $348.8 $411.2
Inventory $545 $584.6 $542.6 $503.5
Total current assets $1231.9 $1237.5 $1208.2 $1260.8
Long term investments $71.4 $79.9 $77.5 $81.9
Property, plant & equipment $424.4 $415 $410 $402.1
Goodwill & intangible assets $1060 $1030.1 $1076.6 $1111.7
Total noncurrent assets $1809.6 $1758.4 $1803 $1854.7
Total investments $71.4 $79.9 $77.5 $81.9
Total assets $3041.5 $2995.9 $3011.2 $3115.5
Current liabilities
Accounts payable $251.5 $283.5 $265.5 $249.1
Deferred revenue $87.3 $73.1 $73.7 $81.7
Short long term debt
Total current liabilities $563.8 $578.8 $571.9 $583.2
Long term debt $871.7 $910.1 $888.8 $897.5
Total noncurrent liabilities $1112.9 $1141.5 $1131 $1202
Total debt $871.7 $910.1 $888.8 $897.5
Total liabilities $1676.7 $1720.3 $1702.9 $1785.2
Shareholders' equity
Retained earnings $1795.8 $1761.9 $1751.3 $1735.6
Other shareholder equity -$45.3 -$90.9 -$47.6 -$17.8
Total shareholder equity $1364.8 $1275.6 $1308.3 $1330.3
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $163 $202.9 $745.25 $641.45
Short term investments
Net receivables $355.5 $505.1 $200.76 $141.35
Inventory $545 $501 $201.37 $215.95
Total current assets $1231.9 $1308.6 $1238.41 $1101.16
Long term investments $71.4 $73.1 $73.69 $57.67
Property, plant & equipment $424.4 $472.1 $272.79 $272.51
Goodwill & intangible assets $1060 $1168 $172.84 $177.13
Total noncurrent assets $1809.6 $1902 $648.6 $611.39
Total investments $71.4 $73.1 $73.69 $57.67
Total assets $3041.5 $3210.6 $1887.01 $1712.55
Current liabilities
Accounts payable $251.5 $276.8 $75.63 $64.06
Deferred revenue $87.3 $80.6 $50.88 $44.94
Short long term debt
Total current liabilities $563.8 $630 $267.74 $233.84
Long term debt $871.7 $941.6
Total noncurrent liabilities $1112.9 $1241.7 $69.03 $71.08
Total debt $871.7 $941.6 $34.35
Total liabilities $1676.7 $1871.7 $336.76 $304.91
Shareholders' equity
Retained earnings $1795.8 $1714.3 $1570.86 $1341.23
Other shareholder equity -$45.3 $11.5 -$5.53 $1.41
Total shareholder equity $1364.8 $1338.9 $1550.24 $1407.66
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $548.9 $478.9 $455.3 $565
Cost of revenue $286.2 $244.1 $234.1 $280.2
Gross Profit $262.7 $234.8 $221.2 $284.8
Operating activities
Research & development $38 $46.5 $40.2 $50.5
Selling, general & administrative $159.9 $156.1 $151.7 $196.3
Total operating expenses $218.7 $209.6 $191.9 $246.8
Operating income $44 $25.2 $29.3 $38
Income from continuing operations
EBIT $23.1 $14 $24.8 $26.2
Income tax expense -$10.8 $3.4 $9.1 $4.9
Interest expense
Net income
Net income $33.9 $10.6 $15.7 $21.3
Income (for common shares) $33.9 $10.6 $15.7 $21.3
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2048.1 $2035.8 $1239.15 $1143.74
Cost of revenue $1044.6 $977 $430.81 $400.68
Gross Profit $1003.5 $1058.8 $808.35 $743.07
Operating activities
Research & development $175.2 $191.4 $137.23 $118.66
Selling, general & administrative $664 $657.4 $395.29 $369.06
Total operating expenses $867 $848.8 $532.52 $487.24
Operating income $136.5 $210 $275.82 $255.82
Income from continuing operations
EBIT $88.1 $193.4 $274.38 $263.76
Income tax expense $6.6 $49.9 $44.73 $23.45
Interest expense
Net income
Net income $81.5 $143.5 $229.65 $240.3
Income (for common shares) $81.5 $143.5 $229.65 $240.3
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $33.9 $10.6 $15.7 $21.3
Operating activities
Depreciation $22.5 $24.5 $25.2 $26.1
Business acquisitions & disposals $7.5
Stock-based compensation $9.4 -$1.1 -$8.6 $7.3
Total cash flows from operations $77.1 -$7 $23.6 $0.4
Investing activities
Capital expenditures -$10.9 -$12.7 -$11.9 -$8.5
Investments
Total cash flows from investing -$25.3 -$22.4 -$22.4 -$11.1
Financing activities
Dividends paid
Sale and purchase of stock $0.3 $0.7 $1.1 $4.9
Net borrowings -$36.4 $18.6 -$5.4 -$28
Total cash flows from financing -$36.3 $19.3 -$4.9 -$35.2
Effect of exchange rate $20.4 -$16.2 -$18.8 $17.4
Change in cash and equivalents $35.9 -$26.3 -$22.5 -$28.5
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $81.5 $143.5 $229.65 $240.3
Operating activities
Depreciation $98.3 $136.1 $35.62 $29.3
Business acquisitions & disposals $7.5 -$999.7 -$116.08
Stock-based compensation $7 $47.7 $44.62 $42.23
Total cash flows from operations $94.1 $29.4 $264.75 $210.96
Investing activities
Capital expenditures -$44 -$52.8 -$25.5 -$72.55
Investments $120
Total cash flows from investing -$81.2 -$1057.7 -$37.53 -$82.79
Financing activities
Dividends paid
Sale and purchase of stock $7 -$393.4 -$105.68 -$52.12
Net borrowings -$51.2 $939.2
Total cash flows from financing -$57.1 $520.4 -$122.4 -$54.31
Effect of exchange rate $2.8 -$30.9 -$1.45 $3.06
Change in cash and equivalents -$41.4 -$538.8 $103.37 $76.93
Fundamentals
Market cap $7.75B
Enterprise value $8.46B
Shares outstanding 52.80M
Revenue $2.05B
EBITDA $186.40M
EBIT $88.10M
Net Income $81.50M
Revenue Q/Q -11.04%
Revenue Y/Y N/A
P/E ratio 95.14
EV/Sales 4.13
EV/EBITDA 45.40
EV/EBIT 96.05
P/S ratio 3.79
P/B ratio 5.50
Book/Share 26.71
Cash/Share 3.09
EPS $1.54
ROA 2.68%
ROE 6.18%
Debt/Equity 1.23
Net debt/EBITDA 8.12
Current ratio 2.18
Quick ratio 1.22